The mission of the UW/FHCRC CFAR Developmental Core is to create a generation of young, innovative, interdisciplinary HIV/AIDS researchers and to foster collaboration among UW/FHCRC CFAR investigators. This mission is articulated through three specific aims, the first of which is to provide research support and mentoring to junior investigators at institutions affiliated with the UW/FHCRC CFAR. Our New Investigator Awards (NIAs), which have successfully fostered the careers of 62 HIV/AIDS investigators since the program's beginning, will continue with modifications to prioritize applications in areas of importance to CFAR's Strategic Research priorities each year and further enhance mentorship through facilitated interawardee networking. Trainee Support Grants (TSGs) used to promote new collaborations will be continued. Additionally, the Core coordinates and collaborates with other CFAR Cores for more specialized developmental award programs, including International Pilot Awards (International Core) and HIV-Associated Malignancy Awards (AIDS-Associated Infections and Malignancies Core);and with OAR, IAS, two other CFARS, and NIH for the Creative and Novel Ideas in HIV Research (CNIHR) program.
The second aim i s to enhance career development, communication among investigators, and multidisciplinary research by sponsoring an annual UW/FHCRC CFAR Symposium.
The third aim i s to provide initial support for HIV/AIDS research in important new research areas (Emerging Opportunity Grants [EOGs]). Innovative aspects of this proposal include enhancing mentorship, a proposed collaboration with the International Core for a Mentored International Investigator Award (MHA), holding a Mock "Study Section" (MSS) for NIA applicants to enhance grant-writing skills, holding a Junior Investigator Poster Session (JIPS) at the annual Symposium, and improved methods for pre- and post-award tracking. The Developmental Core will collaborate with all other CFAR cores and working groups, other CFARS, and research entities such as the UW CTSA;and has specific policies, procedures, and measurable value-added indicators for each core activity. This Core's activities will provide value to the UW/FHCRC and national HIV/AIDS research communities by fostering innovative, interdisciplinary, collaborative HIV/AIDS research now and in the future.

Public Health Relevance

This project will provide support to help young scientists have successful careers as HIV researchers, help UW/FHCRC researchers and researchers communicate and better work together, and fund innovative HIV/AIDS research. The projects and investigators supported by the Core will provide new knowledge about how to prevent HIV infection, how HIV makes people sick, how to treat and eventually cure HIV, and how to decrease HIV-related inequalities.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-UKS-A)
Program Officer
Namkung, Ann S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
United States
Zip Code
Stekler, Joanne D; McKernan, Jennifer; Milne, Ross et al. (2015) Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007-2013. Antivir Ther 20:77-80
Mohanraj, Rani; Jeyaseelan, Visalakshi; Kumar, Shuba et al. (2015) Cultural adaptation of the Brief COPE for persons living with HIV/AIDS in southern India. AIDS Behav 19:341-51
Slyker, Jennifer A; Casper, Corey; Tapia, Kenneth et al. (2014) Accelerated suppression of primary Epstein-Barr virus infection in HIV-infected infants initiating lopinavir/ritonavir-based versus nevirapine-based combination antiretroviral therapy. Clin Infect Dis 58:1333-7
Mackelprang, Romel D; Bigham, Abigail W; Celum, Connie et al. (2014) Toll-like receptor polymorphism associations with HIV-1 outcomes among sub-Saharan Africans. J Infect Dis 209:1623-7
Gantt, Soren; Cattamanchi, Ashok; Krantz, Elizabeth et al. (2014) Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy. J Clin Virol 60:127-32
Puttkammer, Nancy H; Zeliadt, Steven B; Balan, Jean Gabriel et al. (2014) Before and after the earthquake: a case study of attrition from the HIV antiretroviral therapy program in Haiti. Glob Health Action 7:24572
Gerdts, Sarah E; Wagenaar, Bradley H; Micek, Mark A et al. (2014) Linkage to HIV care and antiretroviral therapy by HIV testing service type in Central Mozambique: a retrospective cohort study. J Acquir Immune Defic Syndr 66:e37-44
Liu, Yi; Rao, Ushnal; McClure, Jan et al. (2014) Impact of mutations in highly conserved amino acids of the HIV-1 Gag-p24 and Env-gp120 proteins on viral replication in different genetic backgrounds. PLoS One 9:e94240
Chung, Michael H; Beck, Ingrid A; Dross, Sandra et al. (2014) Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya. J Acquir Immune Defic Syndr 67:246-53
Pantalone, David W; Huh, David; Nelson, Kimberly M et al. (2014) Prospective predictors of unprotected anal intercourse among HIV-seropositive men who have sex with men initiating antiretroviral therapy. AIDS Behav 18:78-87

Showing the most recent 10 out of 552 publications